Keita Sugiyama - Search Results

Year	Number of Results
2014	1
2017	2
2021	2
2022	3
2023	2
2024	1

1

Inhibition of STAT-mediated cytokine responses to chemically-induced colitis prevents inflammation-associated neurobehavioral impairments.

Sin R, Sotogaku N, Ohnishi YN, Shuto T, Kuroiwa M, Kawahara Y, Sugiyama K, Murakami Y, Kanai M, Funakoshi H, Chakraborti A, Bibb JA, Nishi A. Sin R, et al. Among authors: sugiyama k. Brain Behav Immun. 2023 Nov;114:173-186. doi: 10.1016/j.bbi.2023.08.019. Epub 2023 Aug 23. Brain Behav Immun. 2023. PMID: 37625556

2

Effects of advanced glycation end products on dental pulp calcification.

Sugiyama K, Miura J, Shimizu M, Takashima A, Matsuda Y, Kayashima H, Okamoto M, Nagashima T, Araki T. Sugiyama K, et al. Oral Dis. 2022 Apr;28(3):745-755. doi: 10.1111/odi.13792. Epub 2021 Feb 11. Oral Dis. 2022. PMID: 33539626

3

Direct synthesis of cyanate anion from dinitrogen catalysed by molybdenum complexes bearing pincer-type ligand.

Itabashi T, Arashiba K, Egi A, Tanaka H, Sugiyama K, Suginome S, Kuriyama S, Yoshizawa K, Nishibayashi Y. Itabashi T, et al. Among authors: sugiyama k. Nat Commun. 2022 Oct 24;13(1):6161. doi: 10.1038/s41467-022-33809-5. Nat Commun. 2022. PMID: 36280675 Free PMC article.

4

Biological Evaluation of the Effect of Root Canal Sealers Using a Rat Model.

Okamoto M, Matsumoto S, Moriyama K, Huang H, Watanabe M, Miura J, Sugiyama K, Hirose Y, Mizuhira M, Kuriki N, Leprince JG, Takahashi Y, Kawabata S, Hayashi M. Okamoto M, et al. Among authors: sugiyama k. Pharmaceutics. 2022 Sep 24;14(10):2038. doi: 10.3390/pharmaceutics14102038. Pharmaceutics. 2022. PMID: 36297473 Free PMC article.

5

Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia.

Sugiyama K, Kuroiwa M, Shuto T, Ohnishi YN, Kawahara Y, Miyamoto Y, Fukuda T, Nishi A. Sugiyama K, et al. J Neurosci. 2021 Jul 28;41(30):6388-6414. doi: 10.1523/JNEUROSCI.0373-21.2021. Epub 2021 Jun 15. J Neurosci. 2021. PMID: 34131032 Free PMC article.

6

Glycation promotes pulp calcification in Type 2 diabetes rat model.

Takashima A, Miura J, Sugiyama K, Shimizu M, Okada M, Otani T, Nagashima T, Tsuda T, Araki T. Takashima A, et al. Among authors: sugiyama k. Oral Dis. 2024 Mar;30(2):593-603. doi: 10.1111/odi.14529. Epub 2023 Mar 13. Oral Dis. 2024. PMID: 36843542

7

Varenicline aggravates plaque formation through α7 nicotinic acetylcholine receptors in ApoE KO mice.

Koga M, Kanaoka Y, Ohkido Y, Kubo N, Ohishi K, Sugiyama K, Yamauchi A, Kataoka Y. Koga M, et al. Among authors: sugiyama k. Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):194-7. doi: 10.1016/j.bbrc.2014.10.150. Epub 2014 Nov 5. Biochem Biophys Res Commun. 2014. PMID: 25449275 Free article.

8

Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α₇ nAChR in macrophages.

Kanaoka Y, Koga M, Sugiyama K, Ohishi K, Kataoka Y, Yamauchi A. Kanaoka Y, et al. Among authors: sugiyama k. Toxicology. 2017 Apr 1;380:62-71. doi: 10.1016/j.tox.2017.02.006. Epub 2017 Feb 12. Toxicology. 2017. PMID: 28202387

9

Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis.

Koga M, Kanaoka Y, Sugiyama K, Ohishi K, Ejima Y, Hisanaga M, Kataoka Y, Yamauchi A. Koga M, et al. Among authors: sugiyama k. Toxicology. 2017 Sep 1;390:1-9. doi: 10.1016/j.tox.2017.08.006. Epub 2017 Aug 24. Toxicology. 2017. PMID: 28842382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year